News

United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4.

Way back at the beginning of the year, when I was asked to create content and a schedule for the Future Leaders blog posts, I decided that I would write…

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…

London & Manchester, UK, 27 November, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company…

A GENE previously identified as playing a role in eczema, asthma, and allergic rhinitis has been pinpointed as being associated with the incidence of…

EXPOSURE of pregnant mothers to dogs, as well as early contact between children and canine-specific bacteria, may reduce the risk of childhood eczema and…

AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…